SCHEMBL7070110

SCHEMBL7070110

CC(C)CNC(=O)c1ccc(CNc2nc(NCC(C)C)nc3ccsc23)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 2/20 0.56
ADORA2B P29275 8/20 0.48
ADORA2A P29274 8/20 0.48
PDE4A P27815 6/20 0.48
PDE4B Q07343 6/20 0.48
PDE4C Q08493 6/20 0.48
PDE4D Q08499 6/20 0.48
PDE3B Q13370 3/20 0.48
PDE3A Q14432 3/20 0.48
PAK4 O96013 1/20 0.48
MAPK8 P45983 1/20 0.48
TYRO3 Q06418 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
USP1 O94782 1/20 0.45
WDR48 Q8TAF3 1/20 0.45
ADORA1 P30542 1/20 0.41
NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7071282 0.90 PDE4A (0.53) LRRK2ADORA2BADORA2APDE4APDE4B
SCHEMBL7066909 0.75 ADORA2A (0.48) LRRK2ADORA2BADORA2APDE4APDE4B
SCHEMBL7254877 0.73 MAPT (0.50) CLK4
SCHEMBL7071101 0.73 ADORA2A (0.53) LRRK2ADORA2BADORA2APDE4APDE4B
SCHEMBL30092880 0.73 PDE4A (0.52) LRRK2PDE4APDE4BPDE4CPDE4D
SCHEMBL21567306 0.73 PDE4A (0.52) LRRK2PDE4APDE4BPDE4CPDE4D
SCHEMBL21567304 0.73 PDE4A (0.52) LRRK2PDE4APDE4BPDE4CPDE4D
SCHEMBL30092963 0.73 PDE4A (0.52) LRRK2PDE4APDE4BPDE4CPDE4D
SCHEMBL21542001 0.72 PDE4A (0.49) LRRK2ADORA2BPDE4APDE4BPDE4C
SCHEMBL20399148 0.72 PDE4A (0.67) LRRK2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055890-A1 THIENOPYRIMIDINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed